Understanding how Mycoplasma pneumoniae bacteria affect chronic respiratory diseases.
Causes and consequences of virulence factor attenuation in Mycoplasma pneumoniae biofilms
This study is looking at how a type of bacteria called Mycoplasma pneumoniae behaves when it forms clusters, which might help us understand why it can cause long-lasting lung problems like pneumonia and asthma, and the researchers hope to find new ways to help people feel better.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Miami University Oxford NIH-funded |
| Lab location | 1 site (Oxford, United States) |
| Project ID | NIH-10873577 on NIH RePORTER |
What this research studies
This research investigates how the bacteria Mycoplasma pneumoniae produce fewer harmful factors when they grow in biofilm structures, which may contribute to chronic respiratory diseases like pneumonia and asthma. The researchers aim to understand the conditions that allow these bacteria to persist in the lungs and how they interact with respiratory cells. By studying these interactions in a controlled laboratory setting, they hope to identify potential therapeutic strategies to mitigate the negative effects of these infections on patients' health.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from chronic respiratory conditions, particularly those with pneumonia or asthma linked to Mycoplasma pneumoniae infections.
Not a fit: Patients with acute respiratory infections not related to Mycoplasma pneumoniae may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that reduce the impact of chronic respiratory diseases caused by Mycoplasma pneumoniae.
How similar studies have performed: While the specific approach of studying Mycoplasma pneumoniae biofilms is relatively novel, similar research on bacterial biofilms has shown promising results in understanding chronic infections.
Where this research is happening
Oxford, United States
- Miami University Oxford — Oxford, United States (Active)
Researchers
- Principal investigator: Balish, Mitchell F — Miami University Oxford
- Study coordinator: Balish, Mitchell F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.